1. Home
  2. UNCY vs MHH Comparison

UNCY vs MHH Comparison

Compare UNCY & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • MHH
  • Stock Information
  • Founded
  • UNCY 2016
  • MHH 1986
  • Country
  • UNCY United States
  • MHH United States
  • Employees
  • UNCY N/A
  • MHH N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • MHH Professional Services
  • Sector
  • UNCY Health Care
  • MHH Consumer Discretionary
  • Exchange
  • UNCY Nasdaq
  • MHH Nasdaq
  • Market Cap
  • UNCY 91.0M
  • MHH 87.6M
  • IPO Year
  • UNCY 2021
  • MHH N/A
  • Fundamental
  • Price
  • UNCY $6.34
  • MHH $6.57
  • Analyst Decision
  • UNCY Strong Buy
  • MHH
  • Analyst Count
  • UNCY 4
  • MHH 0
  • Target Price
  • UNCY $6.38
  • MHH N/A
  • AVG Volume (30 Days)
  • UNCY 867.0K
  • MHH 12.6K
  • Earning Date
  • UNCY 08-13-2025
  • MHH 08-06-2025
  • Dividend Yield
  • UNCY N/A
  • MHH N/A
  • EPS Growth
  • UNCY N/A
  • MHH N/A
  • EPS
  • UNCY N/A
  • MHH 0.17
  • Revenue
  • UNCY N/A
  • MHH $200,437,000.00
  • Revenue This Year
  • UNCY N/A
  • MHH $1.22
  • Revenue Next Year
  • UNCY $1,458.53
  • MHH $5.41
  • P/E Ratio
  • UNCY N/A
  • MHH $38.19
  • Revenue Growth
  • UNCY N/A
  • MHH 3.93
  • 52 Week Low
  • UNCY $2.02
  • MHH $6.20
  • 52 Week High
  • UNCY $11.00
  • MHH $16.00
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 48.29
  • MHH 41.58
  • Support Level
  • UNCY $4.70
  • MHH $6.39
  • Resistance Level
  • UNCY $7.58
  • MHH $6.85
  • Average True Range (ATR)
  • UNCY 1.20
  • MHH 0.40
  • MACD
  • UNCY -0.07
  • MHH 0.04
  • Stochastic Oscillator
  • UNCY 26.03
  • MHH 19.27

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About MHH Mastech Digital Inc

Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.

Share on Social Networks: